ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $316 | -15.7% | 2,317 | -6.5% | 0.00% | 0.0% |
| Q1 2024 | $375 | +13.3% | 2,479 | -5.7% | 0.00% | 0.0% |
| Q4 2023 | $331 | +28.3% | 2,630 | -4.5% | 0.00% | 0.0% |
| Q3 2023 | $258 | +1.2% | 2,754 | -3.8% | 0.00% | 0.0% |
| Q2 2023 | $255 | -19.6% | 2,862 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $317 | -14.8% | 2,959 | -3.0% | 0.00% | -33.3% |
| Q4 2022 | $372 | -99.9% | 3,051 | +1.0% | 0.00% | 0.0% |
| Q3 2022 | $312,000 | +8.3% | 3,022 | -2.5% | 0.00% | +50.0% |
| Q2 2022 | $288,000 | -8.9% | 3,098 | +15.2% | 0.00% | 0.0% |
| Q1 2022 | $316,000 | +1.0% | 2,689 | +15.9% | 0.00% | 0.0% |
| Q4 2021 | $313,000 | -25.3% | 2,321 | -11.5% | 0.00% | -33.3% |
| Q3 2021 | $419,000 | +44.5% | 2,623 | +19.3% | 0.00% | +50.0% |
| Q2 2021 | $290,000 | -10.2% | 2,198 | -12.5% | 0.00% | 0.0% |
| Q1 2021 | $323,000 | -25.6% | 2,512 | -3.5% | 0.00% | -33.3% |
| Q4 2020 | $434,000 | +958.5% | 2,602 | +885.6% | 0.00% | – |
| Q3 2020 | $41,000 | +41.4% | 264 | +1.9% | 0.00% | -100.0% |
| Q2 2020 | $29,000 | 0.0% | 259 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -19.4% | 259 | 0.0% | 0.00% | – |
| Q4 2019 | $36,000 | +28.6% | 259 | -11.0% | 0.00% | – |
| Q3 2019 | $28,000 | -15.2% | 291 | +2.5% | 0.00% | – |
| Q2 2019 | $33,000 | +10.0% | 284 | +10.9% | 0.00% | – |
| Q1 2019 | $30,000 | +76.5% | 256 | -7.6% | 0.00% | – |
| Q4 2018 | $17,000 | +30.8% | 277 | +56.5% | 0.00% | – |
| Q3 2018 | $13,000 | +8.3% | 177 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 177 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | – | 177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
| Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
| Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
| VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
| EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
| Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
| Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
| Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
| Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
| Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |